# GlenRock Israel

> GlenRock Israel is a VC fund in Herzliya backing Software and Health Care. See 35 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Herzliya, Israel
- Total investments: 35
- Last investment: May 2026
- Lead investor: 3%
- Last updated: Aug 2026
- Website: http://www.grg.co.il

GlenRock Israel is a VC fund in Herzliya focused on Software and Health Care. GlenRock Group leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.

## Contacts

5 contacts available for GlenRock Israel. Shizune tracks 5 team members at GlenRock Israel. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/glenrock-israel?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1M–$9M |
| Series A | $1.5M–$9M |
| Series B | $100k–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 5 | 14% |
| Health Care | 4 | 11% |
| Cyber Security | 4 | 11% |
| Medical Device | 3 | 9% |
| Transportation | 3 | 9% |

67 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 10 | 29% |
| Series A | 6 | 17% |
| Series B | 6 | 17% |
| Funding Round | 5 | 14% |
| Series C | 3 | 9% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 18 | 51% |
| United States | 5 | 14% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Asaf Iram | Investment Manager | 0 | https://shizune.co/investors/profile/asaf-iram |
| Leon Recanati | Founder, Chairman and CEO | 7 | https://shizune.co/investors/profile/leon-recanati-glenrock-israel |
| Ronit Izraeli | Chief Financial Officer | 0 | https://shizune.co/investors/profile/ronit-izraeli |
| Shula Recanati | Managing Partner | 0 | https://shizune.co/investors/profile/shula-recanati |
| Daniel Recanati | Partner | 35 | https://shizune.co/investors/profile/daniel-recanati |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MSICS Pharma | MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose. | $3.6M | Seed | May 03, 2026 |  |
| Treetoscope | The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology. | $7M | Seed | Sep 20, 2023 |  |
| Quris | Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharmacompanies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel. | $9M | Seed | Dec 20, 2022 |  |
| Constru | Constru offers a breakthrough computer vision technology to superpower the engineering and project management teams onsite, monitoring every job, on every wall, throughout the construction process. The system collects and analyses photographic data and generates prescriptive insights to support business decisions and help the teams reliably delivertop-quality projects on time and on budget. | $8M | Series A | Sep 28, 2022 |  |
| AcadeMe+ | AcadeMe+ is an online education platform that provides video-based interactive lessons on skills, enriching social, and emotional teaching. | $750K | Seed | Apr 01, 2022 |  |
| Quris | Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharmacompanies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel. | $19M | Seed | Jan 11, 2022 |  |
| Cylus | Cylus was founded to help mainline and urban railway companies avoid safety incidents and service disruptions caused by cyber-attacks. ‍ Cylus offers solutions that are specifically designed to address the unique requirements and needs of the railway industry, enabling to detect cyber threats in signaling and control networks, trackside andonboard, facilitating an effective response before harm happens. ‍ Led by veterans from the elite technological unit of the Israel Defense Forces’ Intelligence Corps, together with top executives from the railway industry, Cylus’ team combines deep expertise in cybersecurity and rail. | $30M | Series B | Dec 15, 2021 |  |
| Karamba Security | Karamba Security's patented software detects and prevents cyberattacks on a wide variety of connected devices and systems, including automotive ECUs, Industry 4.0 controllers, enterprise edge devices, and IoT endpoints. Karamba's security solutions are embedded within devices and work automatically, without any need for customer operationand with negligible performance impact. | $10M | Series B | Dec 02, 2021 |  |
| Lydus Medical | Lydus Medical is a start-up company that develops a set of tools for anastomosis of small blood vessels. The company was founded in 2017 and is headquartered in Kfar Saba, Israel. | $2.7M | Seed | May 24, 2021 |  |
| Nurami Medical | Nurami Medical is dedicated to the development of a surgical scaffold platform for the repair, regeneration and safe healing of soft tissues following internal surgeries. Nurami Medical production technology is based on the electrospinning technique. | $6M | Series B | Nov 02, 2020 |  |

10 of 35 investments shown.

## Co-investors
- [Gemini Israel Ventures](https://shizune.co/investors/profile/gemini-israel-funds) — VC Fund, 4 deals together
- [Lightspeed Venture Partners](https://shizune.co/investors/profile/lightspeed-venture-partners) — VC Fund, 4 deals together
- [Welltech Ventures](https://shizune.co/investors/profile/welltech-ventures) — VC Fund, 4 deals together
- [Rhodium](https://shizune.co/investors/profile/rhodium) — VC Fund, 3 deals together
- [StageOne Ventures](https://shizune.co/investors/profile/stageone-ventures) — VC Fund, 3 deals together
- [Viola Ventures](https://shizune.co/investors/profile/violaventures) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [F6 Ventures](https://shizune.co/investors/profile/flat6labs) — VC Fund
- [Oqal](https://shizune.co/investors/profile/oqal) — VC Fund
- [Alesta Yatırım](https://shizune.co/investors/profile/alesta-girisim) — VC Fund

## Featured in investor lists
- [Health Care VC Funds in Israel](https://shizune.co/investors/health-care-vc-funds-israel)
- [Health Care Investors in Middle East](https://shizune.co/investors/health-care-investors-middle-east)
- [Health Care VC Funds in Middle East](https://shizune.co/investors/health-care-vc-funds-middle-east)
- [Hardware Investors in Israel](https://shizune.co/investors/hardware-investors-israel)
- [Hardware VC Funds in Israel](https://shizune.co/investors/hardware-vc-funds-israel)
- [Biotechnology Investors in Middle East](https://shizune.co/investors/biotechnology-investors-middle-east)

## FAQ

### What does GlenRock Israel invest in?

GlenRock Israel invests primarily in Software, Health Care and Cyber Security startups, most often at Seed and Series A stage. Most of the 35 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is GlenRock Israel's check size?

GlenRock Israel typically joins rounds of $1M–$9M at Seed, $1.5M–$9M at Series A and $100k–$30M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds GlenRock Israel participates in.

### How do I contact GlenRock Israel?

Public channels for GlenRock Israel include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at GlenRock Israel?

The team at GlenRock Israel includes Asaf Iram (Investment Manager), Leon Recanati (Founder, Chairman and CEO) and Ronit Izraeli (Chief Financial Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co